etidronate has been researched along with Albright Syndrome in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, PD | 1 |
| Costa, L | 1 |
| Servodio Iammarrone, C | 1 |
| Gigliotti, S | 1 |
| Giuzio, E | 1 |
| Buccafusca, G | 1 |
1 review available for etidronate and Albright Syndrome
| Article | Year |
|---|---|
The use of risedronate in Paget's disease.
Topics: Alkaline Phosphatase; Bone Resorption; Clinical Trials as Topic; Etidronic Acid; Fibrous Dysplasia, | 1999 |
1 other study available for etidronate and Albright Syndrome
| Article | Year |
|---|---|
[Paget's disease: a case history, clinical and therapeutic contribution].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Calcitonin; Etidronic Acid; Female; Fibrous | 1990 |